Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Lisette Okkels Jensen, Michael Mæng, Per Thayssen, Anton Boel Villadsen, Lars Romer Krusell, Hans Erik Botker, Knud Erik Pedersen, Jens Aaroe, Evald Høj Christiansen, Thomas Vesterlund, Knud Noerregaard Hansen, Jan Ravkilde, Hans-Henrik Tilsted Hansen, Jens Flensted Lassen, Leif Thuesen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

23 Citationer (Scopus)

Abstract

Patients with diabetes mellitus have increased risk of in-stent restenosis after coronary stent implantation due to neointimal hyperplasia (NIH). The aim of this study was to use quantitative coronary angiography (QCA) and volumetric intravascular ultrasound (IVUS) to evaluate the effects of the sirolimus-eluting Cypher® stent (SES) and the zotarolimus-eluting Endeavor® stent (ZES) on angiographic late lumen loss and intima hyperplasia in diabetic patients.
OriginalsprogEngelsk
Vol/bind7
Sider (fra-til)323-31
Antal sider9
ISSN1774-024X
DOI
StatusUdgivet - 2011
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater